Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Continuous Glucose Monitoring in Non-Diabetic Population to Compliment Signos Mobile Health Platform: Comprehensive Weight Optimization Program and Customized Lifestyle Modifications

NCT05121844 is registered in ClinicalTrials.gov with Signos Inc as lead sponsor.

NCT NCT05121844
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05121844 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Continuous Glucose Monitoring in Non-Diabetic Population to Compliment Signos Mobile Health Platform: Comprehensive Weight Optimization Program and Customized Lifestyle Modifications
Lead sponsor
Signos Inc
Phase
Not applicable
Overall status
Active, not recruiting
Start date
November 2, 2021
Completion date
November 1, 2027
Enrollment
31,187 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

central obesity, glucose intolerance, metabolic glucose disorders, metabolic syndrome, pre-diabetes, weight loss